CoChat

Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition

Open access
Hong, Andrew L, Tseng, Yuen-Yi, Wala, Jeremiah A, Kim, Won-Jun, Kynnap, Bryan D, Doshi, Mihir B, Kugener, Guillaume, Sandoval, Gabriel J, Howard, Thomas P, Li, Ji, Yang, Xiaoping, Tillgren, Michelle, Ghandi, Mahmhoud, Sayeed, Abeer, Deasy, Rebecca, Ward, Abigail, McSteen, Brian, Labella, Katherine M, Keskula, Paula, Tracy, Adam, Connor, Cora, Clinton, Catherine M, Church, Alanna J, Crompton, Brian D, Janeway, Katherine A, Van Hare, Barbara, Sandak, David, Gjoerup, Ole, Bandopadhayay, Pratiti, Clemons, Paul A, Schreiber, Stuart L, Root, David E, Gokhale, Prafulla C, Chi, Susan N, Mullen, Elizabeth A, Roberts, Charles WM, Kadoch, Cigall, Beroukhim, Rameen, Ligon, Keith L, Boehm, Jesse S, Hahn, William C · 2019 · eLife
Cited by 53

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Renal medullary carcinoma (RMC) is a rare and deadly kidney cancer in patients of African descent with sickle cell trait. We have developed faithful patient-derived RMC models and using whole-genome sequencing, we identified loss-of-function intronic fusion events in one SMARCB1 allele with concurrent loss of the other allele. Biochemical and functional characterization of these models revealed that RMC requires the loss of SMARCB1 for survival. Through integration of RNAi and CRISPR-Cas9 loss-of-function genetic screens and a small-molecule screen, we found that the ubiquitin-proteasome system (UPS) was essential in RMC. Inhibition of the UPS caused a G2/M arrest due to constitutive accumulation of cyclin B1. These observations extend across cancers that harbor SMARCB1 loss, which also require expression of the E2 ubiquitin-conjugating enzyme, UBE2C . Our studies identify a synthetic lethal relationship between SMARCB1 -deficient cancers and reliance on the UPS which provides the foundation for a mechanism-informed clinical trial with proteasome inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.44161

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 53

Metadata

Authors
Hong, A. L., Tseng, Y.-Y., Wala, J. A., Kim, W.-J., Kynnap, B. D., Doshi, M. B., Kugener, G., Sandoval, G. J., Howard, T. P., Li, J., Yang, X., Tillgren, M., Ghandi, M., Sayeed, A., Deasy, R., Ward, A., McSteen, B., Labella, K. M., Keskula, P., Tracy, A., Connor, C., Clinton, C. M., Church, A. J., Crompton, B. D., Janeway, K. A., Van Hare, B., Sandak, D., Gjoerup, O., Bandopadhayay, P., Clemons, P. A., Schreiber, S. L., Root, D. E., Gokhale, P. C., Chi, S. N., Mullen, E. A., Roberts, C. W., Kadoch, C., Beroukhim, R., Ligon, K. L., Boehm, J. S., & Hahn, W. C.
Venue
eLife
Published
2019-03-12
Volume
8
ISSN
2050-084X (ISSN-L)
OpenAlex
W2903048998
Cited by
53
References
15
FWCI
2.22
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition. https://app.cochat.ai/papers/10.7554/elife.44161
The paper
Hong, A. L., Tseng, Y.-Y., Wala, J. A., Kim, W.-J., Kynnap, B. D., Doshi, M. B., Kugener, G., Sandoval, G. J., Howard, T. P., Li, J., Yang, X., Tillgren, M., Ghandi, M., Sayeed, A., Deasy, R., Ward, A., McSteen, B., Labella, K. M., Keskula, P., . . . Hahn, W. C. (2019). Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition. eLife. https://doi.org/10.7554/elife.44161

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.